1. Home
  2. SLNO vs GDYN Comparison

SLNO vs GDYN Comparison

Compare SLNO & GDYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • GDYN
  • Stock Information
  • Founded
  • SLNO 1999
  • GDYN 2006
  • Country
  • SLNO United States
  • GDYN United States
  • Employees
  • SLNO N/A
  • GDYN N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • GDYN Computer Software: Prepackaged Software
  • Sector
  • SLNO Health Care
  • GDYN Technology
  • Exchange
  • SLNO Nasdaq
  • GDYN Nasdaq
  • Market Cap
  • SLNO 1.9B
  • GDYN 1.8B
  • IPO Year
  • SLNO 2014
  • GDYN N/A
  • Fundamental
  • Price
  • SLNO $49.17
  • GDYN $20.80
  • Analyst Decision
  • SLNO Strong Buy
  • GDYN Strong Buy
  • Analyst Count
  • SLNO 6
  • GDYN 7
  • Target Price
  • SLNO $74.83
  • GDYN $18.14
  • AVG Volume (30 Days)
  • SLNO 567.7K
  • GDYN 1.5M
  • Earning Date
  • SLNO 03-05-2025
  • GDYN 02-20-2025
  • Dividend Yield
  • SLNO N/A
  • GDYN N/A
  • EPS Growth
  • SLNO N/A
  • GDYN N/A
  • EPS
  • SLNO N/A
  • GDYN 0.03
  • Revenue
  • SLNO N/A
  • GDYN $328,358,000.00
  • Revenue This Year
  • SLNO N/A
  • GDYN $12.94
  • Revenue Next Year
  • SLNO N/A
  • GDYN $18.35
  • P/E Ratio
  • SLNO N/A
  • GDYN $709.65
  • Revenue Growth
  • SLNO N/A
  • GDYN 4.10
  • 52 Week Low
  • SLNO $36.61
  • GDYN $9.07
  • 52 Week High
  • SLNO $60.92
  • GDYN $24.16
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 56.57
  • GDYN 52.62
  • Support Level
  • SLNO $45.44
  • GDYN $20.48
  • Resistance Level
  • SLNO $49.03
  • GDYN $21.30
  • Average True Range (ATR)
  • SLNO 2.36
  • GDYN 0.75
  • MACD
  • SLNO 0.66
  • GDYN -0.21
  • Stochastic Oscillator
  • SLNO 98.40
  • GDYN 30.86

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.

About GDYN Grid Dynamics Holdings Inc.

Grid Dynamics Holdings Inc provides enterprise-level digital transformation in the areas of search, analytics, and release automation to Fortune 1000 companies. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.

Share on Social Networks: